OBJECTIVE: To develop an image processing-based method to quantify the rate of extravasation of fluorescent contrast agents from tumor microvessels, and to investigate the effect of the tumor vascular disrupting agent combretastatin A-4-P (CA-4-P) on apparent tumor vascular permeability to 40 kDa fluorescein isothiocyanate (FITC) labeled dextran. METHODS: Extravasation of FITC-dextran was imaged in 3 dimensions over time within P22 sarcomas growing in dorsal skin flap "window chambers" in BDIX rats using multiphoton fluorescence microscopy. Image processing techniques were used to segment the data into intra- and extravascular regions or classes. Quantitative estimates of the tissue influx (vascular leakage) rate constant, K(i), were obtain...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...
Objective: To develop an image processing-based method to quantify the rate of extravasation of fluo...
<p><b>A.</b> Representative fluorescence micrographs from two human HEp3 tumors displaying peri-tumo...
The leaky, heterogeneous vasculature of human tumors prevents the even distribution of systemic drug...
The leaky, heterogeneous vasculature of human tumors prevents the even distribution of systemic drug...
International audienceIn solid tumors, rapid local intravascular release of anticancer agents, e.g.,...
International audienceIn solid tumors, rapid local intravascular release of anticancer agents, e.g.,...
International audienceIn solid tumors, rapid local intravascular release of anticancer agents, e.g.,...
The goal of this research was to measure functional vascular volume and vascular permeability in tum...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...
The tumor vascular effects of the tubulin destabilizing agent disodium combretastatinA-4 3-O-phospha...
PURPOSE: Assessing tumor vascular features including permeability and perfusion is essential for dia...
The tumor vascular effects of the tubulin destabilizing agent disodium combretastatinA-4 3-O-phospha...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...
Objective: To develop an image processing-based method to quantify the rate of extravasation of fluo...
<p><b>A.</b> Representative fluorescence micrographs from two human HEp3 tumors displaying peri-tumo...
The leaky, heterogeneous vasculature of human tumors prevents the even distribution of systemic drug...
The leaky, heterogeneous vasculature of human tumors prevents the even distribution of systemic drug...
International audienceIn solid tumors, rapid local intravascular release of anticancer agents, e.g.,...
International audienceIn solid tumors, rapid local intravascular release of anticancer agents, e.g.,...
International audienceIn solid tumors, rapid local intravascular release of anticancer agents, e.g.,...
The goal of this research was to measure functional vascular volume and vascular permeability in tum...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...
The tumor vascular effects of the tubulin destabilizing agent disodium combretastatinA-4 3-O-phospha...
PURPOSE: Assessing tumor vascular features including permeability and perfusion is essential for dia...
The tumor vascular effects of the tubulin destabilizing agent disodium combretastatinA-4 3-O-phospha...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...
In solid tumors, rapid local intravascular release of anticancer agents, e.g., doxorubicin (DOX), fr...